Nivolumab plus Ipilimumab versus Existing Immunotherapies in Patients with PD-L1-Positive Advanced Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis

Cancers
Koichi AndoHironori Sagara

Abstract

No head-to-head trials have compared the efficacy and safety of nivolumab (Niv) plus ipilimumab (Ipi) combination therapy (Niv+Ipi) and existing regimens with immunotherapies approved as first-line treatment in patients with programmed cell death ligand 1 (PD-L1)-positive previously untreated advanced non-small cell lung cancer (NSCLC). We conducted a network meta-analysis of four relevant Phase Ⅲ trials to compare the efficacy and safety of Niv+Ipi, pembrolizumab (Pem) plus platinum-based chemotherapy (PBC) (Pem+PBC), Pem, Niv, or PBC using Bayesian analysis. The primary efficacy endpoint was progression-free survival (PFS) in patients with advanced NSCLC with PD-L1 expression ≥1%. The primary safety endpoint was the incidence of Grade 3-5 drug-related adverse events (G3-5AEs). Efficacy and safety were ranked using surface under the cumulative ranking curve (SUCRA). With regard to PFS, Niv+Ipi was inferior to Pem+PBC, and superior to Pem, Niv, or PBC alone. SUCRA ranking showed Pem+PBC had the highest efficacy for PFS, followed by Niv+Ipi, Niv, PBC, and Pem. The safety outcome analysis revealed Niv+Ipi was generally well tolerated compared to existing immunotherapy regimens. These results provide clinical information regarding...Continue Reading

References

Mar 22, 1996·Science·D R LeachJ P Allison
Sep 5, 2002·Statistics in Medicine·Thomas Lumley
Sep 28, 2004·Statistics in Medicine·G Lu, A E Ades
May 21, 2008·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Jeroen P JansenWiro Stam
Jun 15, 2011·Drugs·Fiona CameronCaroline Perry
Jun 15, 2011·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Jeroen P JansenJoseph C Cappelleri
Jun 15, 2011·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·David C HoaglinAnnabel Barrett
Oct 30, 2012·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Sofia DiasNicky J Welton
Jun 28, 2013·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Sofia DiasA E Ades
Jun 28, 2013·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Sofia DiasA E Ades
Dec 17, 2014·Expert Opinion on Investigational Drugs·Anasuya Gunturi, David F McDermott
Jan 15, 2015·Drugs of Today·E Fulchiero, A Jimeno
Mar 24, 2015·Future Oncology·Julie R BrahmerEvan J Lipson
Dec 17, 2015·Advances in Experimental Medicine and Biology·Lindsey A TorreAhmedin Jemal
Jan 12, 2016·Expert Opinion on Biological Therapy·Lavinia Spain, James Larkin
May 3, 2016·Human Vaccines & Immunotherapeutics·Arun RajanJames L Gulley
May 16, 2017·Pharmacy Practice·Fernanda S ToninRoberto Pontarolo
Jan 10, 2018·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Apr 7, 2018·Radiologic Clinics of North America·Girish S ShroffBradley S Sabloff
Apr 17, 2018·The New England Journal of Medicine·Leena GandhiUNKNOWN KEYNOTE-189 Investigators
Jun 29, 2018·Journal of Thoracic Disease·Paolo Bironzo, Massimo Di Maio
Aug 21, 2018·Expert Opinion on Biological Therapy·Xin Gao, David F McDermott
Sep 12, 2018·The Journal of Allergy and Clinical Immunology·William BusseNecdet B Gunsoy
Oct 4, 2018·The New England Journal of Medicine·Luis Paz-AresUNKNOWN KEYNOTE-407 Investigators
Oct 20, 2018·Future Oncology·Nicole A Carreau, Anna C Pavlick
Apr 9, 2019·The Medical Clinics of North America·Faria NasimGeorge A Eapen
May 9, 2019·Future Oncology·Martin ReckKenneth J O'Byrne
Jun 20, 2019·Cancer Management and Research·Jordi RemonÁlvaro Taus
Jul 20, 2019·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Christoph Jakob AckermannRaffaele Califano
Aug 6, 2019·Mayo Clinic Proceedings·Narjust DumaJulian R Molina
Aug 28, 2019·JAMA : the Journal of the American Medical Association·Kathryn C Arbour, Gregory J Riely
Sep 10, 2019·Therapeutic Advances in Medical Oncology·Jia Li LowRoss A Soo
Sep 29, 2019·The New England Journal of Medicine·Matthew D HellmannSuresh S Ramalingam

❮ Previous
Next ❯

Software Mentioned

SUCRA
OpenBUGS
STATA
Cochrane

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.